Research ArticleOriginal Article
Open Access

The response patterns of infantile spasms to treatments in 156 patients

Hormonal therapy with intravenous synthetic ACTH appears promising

Muhammad T. Alrifai, Ahmad R. Al-Rumayyan, Waleed A. Al-Tuwaijri, Duaa M. Baarmah, Safiyyah A. Asiri, Ahmad H. Bali, Muatassem A. Alsadhan and Shaden H. Alsugheir
Neurosciences Journal January 2022, 27 (1) 40-44; DOI: https://doi.org/10.17712/nsj.2022.1.20210116

References

  1. 1.↵
    1. Chudomelova L,
    2. Morris H. Scantlebury,
    3. Raffo E,
    4. Coppola A,
    5. Betancourth D, et al.
    Modeling new therapies for infantile spasms. Epilepsia, 2010; 51 Suppl 3: p. 27–33.
    OpenUrl
  2. 2.↵
    1. Wong M,
    2. Trevathan E.
    Infantile spasms. Pediatr Neurol 2001; 24: 89–98.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Riikonen, R.
    The latest on infantile spasms. Curr Opin Neurol 2005; 18: 91–95.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Lagae L,
    2. Verhelst H,
    3. Ceulemans B,
    4. Meirleir LD,
    5. Nassogne MG,
    6. Borchgrave VD, et al.
    Treatment and long term outcome in West syndrome: the clinical reality. A multicentre follow up study. Seizure 2010; 19: 159–164.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30: 389–399.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Caraballo R,
    2. Cersósimo R,
    3. Intruvini S,
    4. Pociecha J,
    5. Fejerman N.
    [West’s syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment]. Rev Neurol 1997; 25: 1362–1364. Spanish
    OpenUrlPubMed
  7. 7.↵
    1. Alrifai MT,
    2. AlShaya MA,
    3. Abulaban A,
    4. Alfadhel M.
    Hereditary neurometabolic causes of infantile spasms in 80 children presenting to a tertiary care center. Pediatr Neurol 2014; 51: 390–397.
    OpenUrl
  8. 8.↵
    1. Al-Abdulkareem AA,
    2. Ballal SG.
    Consanguineous marriage in an urban area of Saudi Arabia: rates and adverse health effects on the offspring. J Community Health 1998; 23: 75–83.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. El-Mouzan MI,
    2. Al-Salloum AA,
    3. Al-Herbish AS,
    4. Qurachi MM,
    5. Al-Omar AA.
    Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi Med J 2007; 28: 1881–1884.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Elterman RD,
    2. Shields WD,
    3. Mansfield KA,
    4. Nakagawa J
    , US Infantile Spasms Vigabatrin Study Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001; 57: 1416–14121.
    OpenUrlCrossRef
  11. 11.↵
    1. Lux AL,
    2. Edwards SW,
    3. Hancock E,
    4. Johnson AL,
    5. Kennedy CR,
    6. Newton RW.
    The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005; 4: 712–717.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Kossoff EH,
    2. Hartman AL,
    3. Rubenstein JE,
    4. Vining EPG.
    High-dose oral prednisolone for infantile spasms: an effective and less expensive alternative to ACTH. Epilepsy Behav 2009; 14: 674–676.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Mackay MT,
    2. Weiss SK,
    3. Adams-Webber T,
    4. Ashwal S,
    5. Stephens D,
    6. Ballaban-Gill K, et al.
    Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004; 62: 1668–1681.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Jaseja H.
    Drug-choice in management of West syndrome (infantile spasms): Early ACTH treatment may offer a better prognostic outcome. Medical hypotheses 2008; 70: 197–198.
    OpenUrlPubMed
  15. 15.↵
    1. Riikonen R.
    Infantile Spasms: Outcome in Clinical Studies. Pediatr Neurol 2020; 108: 54–64.
    OpenUrlPubMed
  16. 16.↵
    1. O’Callaghan FJ,
    2. Lux AL,
    3. Darke K,
    4. Edwards SW,
    5. Hancock E,
    6. Johnson AL.
    The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia 2011; 52: 1359–1364.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Lux AL,
    2. Osborne JP.
    A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004; 45: 1416–1428.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Shevell MI,
    2. Majnemer A,
    3. Rosenbaum P,
    4. Abrahamowicz M.
    Etiologic determination of childhood developmental delay. Brain & development 2001; 23: 228–235.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Aicardi J,
    2. Mumford JP,
    3. Dumas C,
    4. Wood S.
    Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups. Epilepsia 1996; 37: 638–642.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Nelson GR.
    Management of infantile spasms. Transl Pediatr 2015; 4: 260–270.
    OpenUrl
  21. 21.↵
    1. Fejerman N,
    2. Cersósimo R,
    3. Caraballo R,
    4. Grippo J,
    5. Corral S,
    6. Martino RH, et al.
    Vigabatrin as a first-choice drug in the treatment of West syndrome. J Child Neurol 2000; 15: 161–165.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Karvelas G,
    2. Lortie A,
    3. Scantlebury MH,
    4. Duy PT,
    5. Cossette P,
    6. Carmant L.
    A retrospective study on aetiology based outcome of infantile spasms. Seizure 2009; 18: 197–201.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Hancock E,
    2. Osborne JP.
    Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999; 14: 71–74.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Go CY,
    2. Mackay MT,
    3. Weiss SK,
    4. Stephens D,
    5. Adams-Webber T,
    6. Ashwal S, et al.
    Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2012; 78: 1974–1980.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Hrachovy RA,
    2. Frost Jr JD,
    3. Kellaway P,
    4. Zion TE.
    Double-blind study of ACTH vs prednisone therapy in infantile spasms. J Pediatr 1983; 103: 641–645.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Snead OC, 3rd.,
    2. Benton JW,
    3. Myers GJ.
    ACTH and prednisone in childhood seizure disorders. Neurology 1983; 33: 966–970.
    OpenUrlCrossRef
  27. 27.↵
    1. Riikonen R,
    2. Lahdetie J,
    3. Kokki H.
    ACTH Treatment of Infantile Spasms: Low-Moderate- Versus High-Dose, Natural Versus Synthetic ACTH-A Retrospective Cohort Study. Pediatr Neurol 2020; 111: 46–50.
    OpenUrl
  28. 28.↵
    1. Baram TZ,
    2. Mitchell WG,
    3. Tournay A,
    4. Snead OC,
    5. Hanson RA,
    6. Horton EJ.
    High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996; 97: 375–379.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Hussain SA,
    2. Shinnar S,
    3. Kwong G,
    4. Lerner JT,
    5. Matsumoto JH,
    6. Wu JY, et al.
    Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone. Epilepsia 2014; 55: 103–107.
    OpenUrl
  30. 30.↵
    1. Eliyan Y,
    2. Heesch J,
    3. Alayari A,
    4. Rajaraman RR,
    5. Sankar R,
    6. Hussain SA.
    Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol. Pediatr Neurol 2019; 99: 16–22.
    OpenUrl
  31. 31.↵
    1. O’Callaghan FJK,
    2. Edwards SW,
    3. Alber FD,
    4. Hancock E,
    5. Johnson AL,
    6. Kennedy CR.
    Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol 2017; 16: 33–42.
    OpenUrlPubMed
  32. 32.↵
    1. Mohamed BP,
    2. Scott RC,
    3. Desai N,
    4. Gutta P,
    5. Patil S.
    Seizure outcome in infantile spasms--a retrospective study. Epilepsia 2011; 52: 746–752.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section